Posts tagged Miti at BloggingStocks

Posts with tag miti

Analyst initiations: BEC, BT and MITI

Posted May 29th 2008 11:16AM by Eric Buscemi
Filed under: Yahoo! (YHOO), Analyst initiations

MOST NOTEWORTHY: Beckman Coulter, BT Group and Micromet were today's noteworthy initiations:

Oppenheimer believes Beckman Coulter (NYSE:BEC) is well-positioned to leverage its broad installed base in the clinical lab market to increase sales of its consumable and a new molecular diagnostics instrument expected in 2010. The firm initiated shares with an Outperform rating and $80 target.
Societe Generale expects BT Group's (NYSE:BT) domestic revenues to deteriorate as line erosion accelerates; shares were assumed with a Sell rating.
Roth Capital started Micromet (NASDAQ:MITI) with a Buy rating and $3 target. The firm expects the company's proprietary 'BiTE' antibody platform to gain validation as its lead candidate MT103 starts accumulating clinical data in multiple hematology indications.

OTHER INITIATIONS:

Yahoo! (NASDAQ:YHOO) was initiated with a Neutral rating at Merrill.
Piper resumed coverage of Alexion Pharma (NASDAQ:ALXN) with a Buy rating and $88 target.
MedAssets (NASDAQ:MDAS) was started at Jefferies with a Buy rating and $25 target.

MOST NOTEWORTHY: Abbott Lab, Fannie Mae, Freddie Mac and Micromet were today's noteworthy upgrades:

Wachovia upgraded Abbott Lab (NYSE: ABT) to Outperform from Market Perform as they believe their earlier concerns have been addressed. Past concerns included the potential for a negative outcome from the FDA panel on Xience and slowing prescription growth of lead drug Humira.
Fannie Mae (NYSE: FNM) and Freddie Mac (NYSE: FRE) were raised to Outperform from Market Perform at Keefe Bruyette citing recent government actions to stabilize the mortgage markets.
Micromet (NASDAQ: MITI) was upgraded at RBC Capital to Outperform from Sector Perform as they expect positive data for its lead candidate, MT103, by year-end.

OTHER UPGRADES:

#	Blogger	Posts	Cmts
1	Douglas McIntyre	118	0
2	Joseph Lazzaro	80	0
3	Peter Cohan	76	0
4	Zac Bissonnette	75	0
5	Brian White	41	1
6	Steven Halpern	41	0
7	Steven Mallas	36	0
8	Melly Alazraki	32	0
9	Jonathan Berr	31	0
10	Tom Taulli	30	0
11	Sheldon Liber	24	0
12	Larry Schutts	22	0
13	Jim Cramer	22	0
14	Paul Foster	21	0
15	Brent Archer	21	0
16	Trey Thoelcke	17	0
17	Jon Ogg	17	0
18	Daniel Solin	14	0
19	Eric Buscemi	14	0
20	Elizabeth Harrow	11	0

Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

Other Weblogs Inc. Network blogs you might be interested in:

VC business 'incredibly tough,' says PE investor Oracle reels in ClearApp Microsoft pays $486 million for Greenfield Online	Online ad trend get worse for Yahoo!, newpapers 6 'cheap' stocks that aren't, 7 bad borrowing strategies & downsized products - Today in Money 9/4 Before the bell: Futures lower; WMT, BA, BP, TOL, MSFT, UL ...
Buy a Mac, get Office at 30% off iPhone App rejected for "Limited Utility" Rumor: iTunes 8 to include Genius recommender, grid view, new visualizer	WebChunks Brings IE8's Slices to Firefox How to organize your ideas in Gmail - Emailers Anonymous Django hits 1.0
Cindy McCain's $300,000 Outfit for the RNC Mulholland Brothers Boardroom Collection Chicago Luxury Home Tour	10 stocks for next 10 years, best credit cards & 12 ways to build a great credit score - Today in Money 9/3 Another marginal product from Google: Business video sharing Analyst calls: SCRX, GOOG, LOW, DF, GILD, EK, SOLR, XRX ...